Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sparacia, G.
Right arrow Articles by Lagalla, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sparacia, G.
Right arrow Articles by Lagalla, R.
(Radiology. 2000;215:818-823.)
© RSNA, 2000


Neuroradiology

Transfusional Hemochromatosis: Quantitative Relation of MR Imaging Pituitary Signal Intensity Reduction to Hypogonadotropic Hypogonadism1

Gianvincenzo Sparacia, MD, Alberto Iaia, MD, Aurelia Banco, MD, Paolo D'Angelo, MD and Roberto Lagalla, MD

1 From the Institute of Radiology, Università di Palermo, Italy (G.S., A.B., R.L.); the Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (A.I.); and the Department of Pediatrics, Thalassemia Service, Ospedale "Villa Sofia," Palermo, Italy (P.D.). Received June 21, 1999; revision requested August 11; revision received September 29; accepted October 20. Address correspondence to G.S., Viale Strasburgo, 167, 90146 Palermo, Italy (e-mail: sparacia@unipa.it).

PURPOSE: To assess the relationship between magnetic resonance (MR) imaging pituitary signal intensity reduction in patients with transfusional hemochromatosis and the clinical manifestation of hypogonadotropic hypogonadism.

MATERIALS AND METHODS: Pituitary MR imaging at 0.5 T was performed in 38 consecutive patients affected by secondary hemochromatosis and in 20 healthy volunteers. Serum ferritin levels were estimated in the affected population. Twenty (53%) of the 38 patients had hypogonadotropic hypogonadism diagnosed. Pituitary-to-fat signal intensity ratios were calculated from coronal gradient-echo (GRE) T2*-weighted MR images. The relationship between the quantitative reduction of the pituitary-to-fat signal intensity ratio and the clinical manifestation of pituitary dysfunction was assessed in the affected population. Signal intensity reduction in the anterior lobe of the pituitary gland was also correlated with the serum ferritin level.

RESULTS: The degree of reduction of the pituitary-to-fat signal intensity ratio correlated with the presence of hypogonadotropic hypogonadism, with a sensitivity of 90%, a specificity of 89%, and an overall accuracy of 89%. In addition, the reduction of pituitary signal intensity was greater in patients with higher ferritin levels (r = -0.55, r2 = -0.30, P < .001).

CONCLUSION: The degree of signal intensity reduction, measured as the pituitary-to-fat signal intensity ratio for GRE T2*-weighted images, in patients with secondary hemochromatosis correlates with the severity of pituitary dysfunction.

Index terms: Anemia, 145.652 • Hemochromatosis, 145.519 • Hormones • Pituitary, diseases, 145.519 • Pituitary, MR, 145.121412




This article has been cited by other articles:


Home page
Postgrad. Med. J.Home page
Multiorgan involvement in thalassaemia major
Postgrad. Med. J., June 1, 2003; 79(932): 361 - 362.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2000 by the Radiological Society of North America.